SenesTech (NASDAQ:SNES) Coverage Initiated at StockNews.com

Equities research analysts at StockNews.com assumed coverage on shares of SenesTech (NASDAQ:SNES) in a research note issued on Monday. The firm set a “sell” rating on the stock.

Separately, HC Wainwright increased their target price on shares of SenesTech from $3.50 to $10.00 and gave the stock a “buy” rating in a research report on Thursday, December 12th.

SenesTech Trading Down 1.3 %

SenesTech stock opened at $2.21 on Monday. The company has a debt-to-equity ratio of 0.05, a current ratio of 6.32 and a quick ratio of 4.92. The company has a market capitalization of $2.29 million, a price-to-earnings ratio of -0.22 and a beta of 0.09. SenesTech has a one year low of $1.90 and a one year high of $9.80. The company’s fifty day moving average price is $2.97 and its two-hundred day moving average price is $2.83.

SenesTech (NASDAQ:SNES) last posted its earnings results on Wednesday, March 12th. The company reported ($1.22) EPS for the quarter, topping the consensus estimate of ($1.50) by $0.28. The firm had revenue of $0.50 million for the quarter, compared to the consensus estimate of $0.71 million. SenesTech had a negative net margin of 403.51% and a negative return on equity of 150.33%. On average, analysts forecast that SenesTech will post -10.22 earnings per share for the current fiscal year.

SenesTech Company Profile

SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.